BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 20805254)

  • 1. Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome.
    Fiorante S; Fernández-Ruiz M; López-Medrano F; Lizasoain M; Lalueza A; Morales JM; San-Juan R; Andrés A; Otero JR; Aguado JM
    Nephrol Dial Transplant; 2011 Mar; 26(3):1065-73. PubMed ID: 20805254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transplant in patients with spinal cord injuries.
    Basiri A; Shakhssalim N; Hosseini-Moghddam SM; Parvaneh MJ; Azadvari M
    Exp Clin Transplant; 2009 Mar; 7(1):28-32. PubMed ID: 19364309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction.
    Zlotnick DM; Axelrod DA; Chobanian MC; Friedman S; Brown J; Catherwood E; Costa SP
    Nephrol Dial Transplant; 2010 Sep; 25(9):3090-6. PubMed ID: 20299337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of patterns of proteinuria on renal allograft function and survival: a prospective cohort study.
    Suhail SM; Kee TS; Woo KT; Tan HK; Yang WS; Chan CM; Foo MW; Li HH; Siddique MM; Wong KS
    Clin Transplant; 2011; 25(3):E297-303. PubMed ID: 21362048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute graft pyelonephritis following renal transplantation.
    Kamath NS; John GT; Neelakantan N; Kirubakaran MG; Jacob CK
    Transpl Infect Dis; 2006 Sep; 8(3):140-7. PubMed ID: 16913972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-associated graft loss in renal transplant recipients.
    Dahle DO; Mjøen G; Oqvist B; Scharnagl H; Weihrauch G; Grammer T; März W; Abedini S; Norby GE; Holme I; Fellström B; Jardine A; Holdaas H
    Nephrol Dial Transplant; 2011 Nov; 26(11):3756-61. PubMed ID: 21511816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term improvement of deceased donor renal allograft survival since 1996: a single transplant center study.
    Sola E; Gonzalez-Molina M; Cabello M; Burgos D; Ramos J; Gutierrez C; Lopez V; Soler J; de la Vega E; Hernandez D
    Transplantation; 2010 Mar; 89(6):714-20. PubMed ID: 20035250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute rejection and late renal transplant failure: risk factors and prognosis.
    Pallardó Mateu LM; Sancho Calabuig A; Capdevila Plaza L; Franco Esteve A
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic subureteral polydimethylsiloxane injection and prevention of recurrent acute graft pyelonephritis.
    Song JC; Hwang HS; Yoon HE; Kim JC; Choi BS; Kim YS; Yang CW
    Nephron Clin Pract; 2011; 117(4):c385-9. PubMed ID: 21071963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preemptive living-donor renal transplantation: outcome and clinical advantages.
    Yoo SW; Kwon OJ; Kang CM
    Transplant Proc; 2009; 41(1):117-20. PubMed ID: 19249492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors, and the impact of allograft pyelonephritis on renal allograft function.
    Singh R; Geerlings SE; Peters-Sengers H; Idu MM; Hodiamont CJ; Ten Berge IJ; Bemelman FJ
    Transpl Infect Dis; 2016 Oct; 18(5):647-660. PubMed ID: 27380002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus.
    Schiel R; Heinrich S; Steiner T; Ott U; Stein G
    Nephrol Dial Transplant; 2005 Mar; 20(3):611-7. PubMed ID: 15689368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study.
    Gutiérrez P; Marrero D; Hernández D; Vivancos S; Pérez-Tamajón L; Rodríguez de Vera JM; Alarcó A; González-Posada JM
    Nephrol Dial Transplant; 2007 May; 22(5):1451-5. PubMed ID: 17327283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy in the early post-renal transplant period.
    Ardalan MR; Shoja MM; Tubbs RS; Etemadi J; Esmaili H; Khosroshahi HT
    Ren Fail; 2008; 30(2):199-203. PubMed ID: 18300121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
    Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
    Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
    Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
    Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of renal transplantation in recipients with Wegener's granulomatosis.
    Shen J; Gill J; Shangguan M; Sampaio MS; Bunnapradist S
    Clin Transplant; 2011; 25(3):380-7. PubMed ID: 20394635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
    Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
    Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.